Trial Profile
Ivabradine in Sepsis for Heart Rate, Benefits and Disadvantages trial (IS-HR-BAD)
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 19 Jul 2016
Price :
$35
*
At a glance
- Drugs Ivabradine (Primary) ; Ivabradine (Primary)
- Indications Sepsis; Sinus tachycardia
- Focus Therapeutic Use
- Acronyms IS-HR-BAD
- 19 Jul 2016 New trial record